To learn more about this report, request sample copy
North America dominates the regulatory affairs outsourcing market with an estimated market share of 40.2% in 2024. With the presence of well-established pharmaceutical companies and robust regulations, North America accounted for over 35% of the global market share in 2021. The region is home to major hubs like U.S. and Canada that boosts demand for outsourcing regulatory functions. Stringent regulations such as FDASIA have necessitated companies to rely on specialized regulatory service providers for ensuring compliance. Presence of leading contract research organizations (CROs) offering end-to-end regulatory solutions drives the market growth. Furthermore, high concentration of clinical trials in this region increases the need for regulatory expertise.
Asia Pacific region is poised to be the fastest growing market during the forecast period. Countries like China, India and Japan are emerging as global sourcing destinations for regulatory affairs due to increasing investments in healthcare infrastructure and pharmaceutical manufacturing capabilities. Supportive government policies promoting the life sciences industry coupled with availability of low-cost regulatory skilled resources are encouraging companies to establish regional hubs in Asia. Rising preference for Asia Pacific CROs owing to their comprehensive capabilities and localized expertise can boost outsourcing activity in this region. In addition, Asia Pacific companies are actively enhancing their global regulatory networks to cater growing international marketing authorizations for their products. While pricing of services is relatively lower compared to mature markets, the region offers high future growth potential backed by improving quality standards.
Regulatory Affairs Outsourcing Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients